期刊文献+

β-tubulin Ⅲ在结肠腺癌组织中的表达及其临床意义 被引量:3

Expression of β-tubulin Ⅲ in colon adenocarcinoma tissue and its clinical significance
下载PDF
导出
摘要 目的:检测结肠腺癌患者癌组织中β-tubulinⅢ的表达,探讨其临床意义。方法:收集结肠腺癌组织标本111例,根据β-tubulinⅢ的阳性细胞分布部位分为浸润前沿组(n=72例)和非浸润前沿组(n=39例),采用免疫组织化学法检测结肠腺癌患者癌组织中β-tubulinⅢ的阳性表达率,分析β-tubulinⅢ的表达与患者性别、年龄、肿瘤分化、临床分期、淋巴结转移、复发和死亡等临床病理特征之间的关系。结果:不同性别、淋巴结转移、临床分期、死亡和复发结肠腺癌患者间β-tubulinⅢ的阳性表达率比较差异无统计学意义(P>0.05)。浸润前沿组和非浸润前沿组患者癌组织中β-tubulinⅢ阳性表达率比较差异有统计学意义(χ~2=8.76,P=0.01)。低中分化病例多见于浸润前沿组,而高分化病例多见于非浸润前沿组(χ~2=6.88,P=0.03)。不同分化程度癌组织中β-tubulinⅢ的阳性表达率比较差异有统计学意义(χ~2=5.74,P=0.04)。非前沿组中有无淋巴结转移的患者癌组织中β-tubulinⅢ阳性表达率比较差异有统计学意义(χ~2=6.02,P=0.05)。免疫组织化学法染色,β-tubulinⅢ阳性表达细胞胞质呈黄色颗粒;与低分化组比较,高分化癌组织中β-tubulinⅢ阳性表达细胞明显增多。结论:结肠腺癌组织中β-tubulinⅢ表达与肿瘤的分化程度有关,高分化结肠腺癌组织多见于非浸润前沿组。非浸润前沿组患者β-tubulinⅢ表达与淋巴结转移有关。 Objective.. To detect the expression and clinical significance of β-tubulin Ⅲ in cancer tissue of the patients with colon adenocarcinoma, and to explore its clinical significance. Methods: A total of Ⅲ colon adenocarcinoma tissue samples were obtained. According to the location of β-tubulin Ⅲ positive cells, all patients were divided into front group (n=72) and non-front group (n=39). The positive expression rate of β-tubulin Ⅲ in the patients with colon adenocarcinoma was detected with immunohistochemistry. The correlations among the expression of β-tubulin Ⅲ and gender, age, tumor differentiation, clinical stage, lymph node metastasis, recurrence and death were analyzed. Results: The expression levels of β-tubulin Ⅲ had no significant differences between the natients with different gerder, age, lymph node metastasis, clinical stages, death and recurrence. The positive expression rates of β-tubulin in cancer tissue of the patients had significant difference between front and non-front groups (X^2 = 8.76, P = 0.01). Lowly-to-moderately differentiated tissue was more common in front group, and highly-differentiated tissue was more common in non-front group (X^2= 6.88, P= 0.03). There were significant differences in the expression levels of β-tubulin Ⅲ between cancer tissues with different differentiation degrees (X^22= 5.74, P= 0.04). In non-front group, lymph node metastasis was closely correlated with the expression of β-tubulin Ill (X^2=6.02, P=0.05). The results of immunohistochemical staining showed that the β- tubulin Ⅲ positive-expressing cells were colored brown-yellow. The number of cells with positive β-tubulin m expression was significantly increased in highly differentiated tissue compared with low-differentiated tissue. Conclusion: The expression of β-tubulin Ⅲ is closely related to tumor differentiation in colon adenocarcinoma tissue. The highly differentiated colon adenocarcinoma tissue is more common in non-front group in which the expression of β-tubulin Ⅲ is related to lymph node metastasis.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2017年第4期770-775,F0003,共7页 Journal of Jilin University:Medicine Edition
基金 天津市卫计委重点攻关项目资助课题(15KG116)
关键词 结肠肿瘤 腺癌 Β-TUBULIN 免疫组织化学 colonic neoplasms adenocarcinoma β-tubulin Ⅲ immunohistochemistry
  • 相关文献

参考文献7

二级参考文献62

  • 1Ming Lu,Jing Gao, Xi-cheng Wang, Lin Shen.Expressions of Thymidylate Synthase, Thymidine Phosphorylase, Class Ⅲ β-tubulin, and Excision Repair Cross-complementing Group 1 Predict Response in Advanced Gastric Cancer Patients Receiving Capecitabine Plus Paclitaxel or Cisplatin[J].Chinese Journal of Cancer Research,2011,23(4):288-294. 被引量:22
  • 2Kang YK,Kang WK,Shin DB, et al.Capecitabine/cisplatin versus 5‐fluorouracil/cisplatin as first‐line therapy in patients with advanced gastric cancer: a randomised phase III noninferioritytrial. Annals of Oncology . 2009
  • 3Puglisi F,Cardellino GG,Crivellari D, et al.Thymidine phosphorylase expression is associated with time to progression in patient receiving low dose, docetaxel‐modulated capecitabine for metastatic breast cancer. Annals of Oncology . 2008
  • 4Napieralski R,Ott K,Kremer M, et al.Combined GADD45A and thymidine phosphorylase expression levels predict response and survival of neoadjuvant treated gastric cancer patients. Clinical Cancer Research . 2005
  • 5Ichikawa W,Takahashi T,Suto K et al.Gene expressions for thymidylate synthase (TS), orotate phosphoribosyltransferase(OPRT), and thymidine phosphorylase (TP), not dihydro‐ pyrimidine dehydrogenase (DPD), influence outcome of patients (pts) treated with S‐1 for gastric cancer (GC). Journal of Clinical Oncology . 2004
  • 6Rosell R,Scagliotti G,Danenberg KD, et al.Transcripts in pretreatment biopsies from a three‐arm randomized trial in metastatic non‐small‐cell lung cancer. Oncegene . 2003
  • 7Dumontet C,Isaac S,Souquet PJ, et al.Expression of class III beta tubulin in non‐small cell lung cancer is correlated with resistance to taxane chemotherapy. Bulletin du Cancer . 2005
  • 8Urano N,Fujiwara Y,Doki Y, et al.Clinical significance of class III beta‐tubulin expression and its predictive value for resistance to docetaxel‐based chemotherapy in gastric cancer. International Journal of Oncology . 2006
  • 9Kwon HC,Roh MS,Oh SY, et al.Prognostic value of expression of ERCC1, thymidylate synth‐ ase, and glutathione S‐transferase P1 for 5‐fluorouracil/oxaliplatin chemotherapy in advanced gastric cancer. Annals of Oncology . 2007
  • 10Bernard-Marty,C,Treilleux,I,Dumontet,C.Microtubule-Associated Parameters as Predictive Markers of Docetaxel Activity in Advanced Breast Cancer Patients: Results of a Pilot Study. Clinical Breast Cancer . 2002

共引文献102

同被引文献21

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部